Tirzepatide (going by the brand names Mounjaro and Zepbound) is the only dual agonist currently approved in Canada
Human and Clinical Evidence Current human research indicates that arginine produces inconsistent effects: modest improvements in vascular function and endurance in some studies, but little to no impact on hypertrophy or resistance performance in pooled analyses
I've seen it happen to countless clients, and it's happened to me as well.
Editorial refresh Practical 2026 note for Best GLP This update makes Best GLP more specific by tying semaglutide, tirzepatide, cash-pay pricing, safety signals, best, glp1 to the page's original clinical, cost, access, or comparison angle
Cardiovasc Diabetol 17:153 Chilton R, Tikkanen I, Cannon CP et al (2015) Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes